Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q4 FY23 results · Jan–Mar 2023
Abbott India reported revenue from operations of ₹1,343.08 crore (up 7.0% from Q4 FY22) and net profit of ₹231.42 crore (up 9.5% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a standalone basis.
| Item | Q4 FY23 | Q4 FY22 | YoY | Q3 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,343.08 | 1,255.02 | +7.0% | 1,326.48 | +1.3% |
| Other income | 49.64 | 21.05 | +135.8% | 39.94 | +24.3% |
| Total income | 1,392.72 | 1,276.07 | +9.1% | 1,366.42 | +1.9% |
| Profit before tax | 308.41 | 292.30 | +5.5% | 334.83 | −7.9% |
| Net profit for the period | 231.42 | 211.41 | +9.5% | 246.83 | −6.2% |
| EPS, basic (₹) | 108.90 | 99.49 | +9.5% | 116.16 | −6.2% |
| Net margin (%) | 17.2 | 16.8 | 18.6 |
Standalone
- Filed with BSE
- 22 May 2023, 12:04 IST
- Board meeting
- 19 May 2023
- Period
- 01 Jan 2023 to 31 Mar 2023
- Review status
- Audited
- Source
- XBRL filing on BSE